In addition to the viral and treatment factors, studies have found that IL28B gene polymorphism is closely related with the treatment response in hepatitis C infection patients treated with PEG-IFN/RBV in the recent years. This evidence concerns the gene IFNL3 and hepatitis C virus infection.